40 studies found for:    Temporal arteritis
Show Display Options
Rank Status Study
21 Completed MRI Superficial Temporal Artery
Condition: Temporal Arteritis
Intervention: Device: MRI
22 Completed Educational Needs of Patients With Systemic Vasculitis
Conditions: Behcet's Disease;   Churg-Strauss Syndrome;   Vasculitis, Central Nervous System;   Giant Cell Arteritis;   Wegener Granulomatosis;   Henoch-Schoenlein Purpura;   Microscopic Polyangiitis;   Polyarteritis Nodosa;   Takayasu's Arteritis
Intervention:
23 Recruiting One-Time DNA Study for Vasculitis
Conditions: Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss);   Giant Cell Arteritis;   Granulomatosis With Polyangiitis (Wegener's);   Microscopic Polyangiitis;   Polyarteritis Nodosa;   Takayasu's Arteritis
Intervention:
24 Completed Vasculitis Illness Perception (VIP) Study
Conditions: Wegener Granulomatosis;   Microscopic Polyangiitis;   Churg-Strauss Syndrome;   Polyarteritis Nodosa;   Giant Cell Arteritis;   Takayasu's Arteritis;   Henoch-Schoenlein Purpura;   Behcet's Disease;   CNS Vasculitis
Intervention:
25 Completed Reproductive Health in Men and Women With Vasculitis
Conditions: Giant Cell Arteritis;   Takayasu's Arteritis;   Polyarteritis Nodosa;   Wegener's Granulomatosis;   Microscopic Polyangiitis;   Churg-Strauss Syndrome;   Behcet's Disease;   Kawasaki Disease;   Henoch-schoenlein Purpura;   Vasculitis, Central Nervous System;   Drug-induced Necrotizing Vasculitis
Intervention:
26 Completed Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.
Conditions: Rheumatoid Arthritis;   Polymyalgia Rheumatica;   Giant Cell Arteritis;   Polymyositis;   Wegener’s Granulomatosis
Intervention: Drug: Alendronate versus alfacalcidol (1-alpha OH vitamin D)
27 Terminated Trial to Study the Effects of Supplementary Omega-3 on Serum C-Reactive Protein Levels
Conditions: Coronary Artery Disease;   Inflammatory Response;   Atherosclerosis
Intervention: Dietary Supplement: eicosapentaenoic acid (EPA),
28 Active, not recruiting Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
Conditions: Uveitis;   Intermediate Uveitis;   Posterior Uveitis;   Panuveitis;   Noninfectious Uveitis
Intervention: Drug: triamcinolone acetonide (Triesence®)
29 Recruiting Magnetic Resonance Angiography vs Ultrasonography in Systemic Large vEssel vasculitiS
Condition: Systemic Vasculitis
Interventions: Device: Ultrasound;   Device: MRA
30 Recruiting Study of Tocilizumab to Treat Polymyalgia Rheumatica
Condition: Polymyalgia Rheumatica (PMR)
Intervention: Drug: Tocilizumab
31 Unknown  Timed Release Tablet Prednisone in Polymyalgia Rheumatica
Condition: Polymyalgia Rheumatica
Interventions: Drug: Timed Release Tablet Prednisone;   Drug: Prednisolone
32 Unknown  Efficacy of Micro-Pulse Steroid Therapy as Induction Therapy in Patients With Polymyalgia Rheumatica
Condition: Polymyalgia Rheumatica
Interventions: Drug: Betamethasone;   Drug: isotonic sodium chloride solution (placebo)
33 Active, not recruiting Protocol For The Quantitation Of Pain In The Diagnosis Of Polymyalgia Rheumatica
Conditions: Polymyalgia Rheumatica;   Rheumatoid Arthritis;   Rheumatic Disease
Intervention:
34 Terminated A Study Assessing the Efficacy and Safety of Lodotra® Compared to Prednisone IR in Subjects Suffering From PMR
Condition: Polymyalgia Rheumatica
Interventions: Drug: Lodotra®;   Drug: Prednisone IR (immediate release)
35 Recruiting Tocilizumab Effect iN pOlymyalgia Rheumatica
Condition: Polymyalgia Rheumatica
Intervention: Drug: TCZ
36 Completed Etanercept Treatment in the Early Course of Polymyalgia Rheumatica
Condition: Polymyalgia Rheumatica
Interventions: Drug: Etanercept (Enbrel);   Drug: Sodium chloride (placebo)
37 Terminated A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia Rheumatica
Conditions: Polymyalgia Rheumatica;   Inflammatory Diseases
Interventions: Drug: AIN457;   Drug: ACZ885 (canakinumab);   Drug: Prednisone
38 Unknown  Infliximab Therapy in Patients With Refractory Polymyalgia Rheumatica
Condition: Polymyalgia Rheumatica
Interventions: Drug: infliximab;   Drug: inactive powder
39 Completed Short Term Efficacy of a Starting Dose of 12.5 mg of Prednisone in Polymyalgia Rheumatica Patients
Condition: Polymyalgia Rheumatica
Intervention: Drug: prednisone
40 Unknown  Steroid-Induced Osteoporosis in the Pediatric Population - Canadian Incidence Study
Conditions: Acute Lymphoblastic Leukemia;   Nephrotic Syndrome;   Rheumatism
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page
Indicates status has not been verified in more than two years